Announced Fri, 3 Jul · 18:02 IST
Compliance certificate for securities dematerialisation for Apr-Jun 2026
Compliance View source PDF
PGHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.7%1-day move
₹6358.50
prior close
₹6371.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
———-0.7-1.7-1.5+3.8+7.1+7.8+7.7+6.8———
Up moveDown movePending
AI summary
Procter & Gamble Health submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ending June 30, 2026. The certificate, issued by the company's Registrar and Transfer Agent Kfin Technologies, confirms that details of shares dematerialised and rematerialised during the quarter were furnished to both BSE and NSE within the required timeline. This is a routine quarterly regulatory filing and does not involve any change in share capital or ownership structure.
Likely market impact
Routine compliance filing. No impact on shareholders, share price, or company financials. No material information for investors.